Work

Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report

Year: 2023

Type: article

Abstract: 75-year-old patient with cochlear implant diagnosed with very low risk prostate cancer (PSA 6.44 ng/mL, and Grade Group 1 (left apical core)) managed on Active Surveillance (AS). After four years monitoring on AS, PSA was observed to increase to 10.84 and patient was reevaluated for disease progression. Due to cochlear implant, multiparametric MRI was not an imaging option and patient was referred for piflufolastat F 18-PET/CT. In addition to previously identified left sided lesion, tracer uptake was observed within the posterior transition and peripheral zone of the right lobe of the prostate, which ultimately confirmed disease progression on targeted biopsy.

Source: Urology Case Reports

DOI: 10.1016/j.eucr.2023.102352

Authors: Tim Grossman, Kathryn A. Morton

Institutions: St. Peter's Hospital, University of Utah

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $900